Effectiveness of Group Acceptance and Commitment Therapy in Treating Acute Stroke Patients With Depression

PLA Rocket Force Characteristic Medical Center

Status

Completed

Conditions

Acute Stroke Patients With Depression

Treatments

Behavioral: Group-based Acceptance and Commitment Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05727358

Z181100001718041

Details and patient eligibility

About

The goal of this clinical trial is to discover the effectiveness of group-based Acceptance and Commitment Therapy (ACT) in treating depression for acute stroke patients. The main question[s] it aims to answer are:

Group-based ACT (G-ACT) could significantly reduce the depressive symptoms in patients with acute stroke,
the interventional efficacy could be maintained at 3-month follow-up
similar benefits would be observed for quality of life (QOL), sleep quality, psychological flexibility, cognitive fusion, and confidence.

The patients included to the control group received usual care support in hospital, and the patients included to the intervention group received G-ACT and usual care support. the G-ACT treatment in this study comprised 7 sessions of 45-60 minutes and was administered throughout the course of the 4-week long trial.

Enrollment

139 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

primary diagnosis of acute stroke, the last onset occurred within 2 weeks
being over 18 years old
scoring at least 8 on the HAMD scale
Be conscious and able to communicate effectively with researchers
Primary school education level or above, 6) having signed informed consent.

Exclusion criteria

having a history of mental illness (such as bipolar disorder) or dementia, using psychiatric drugs or sedatives within 6 months, or currently using antidepressants
a diagnosis of cognitive impairment
receiving a psychological therapy in the previous three months, or currently experiencing severe psychotic symptoms
a history of drug abuse or dependence